Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Significance: We describe an approach based on cytokine therapeutics to enhance the persistence and effectiveness of T-cell–based immunotherapies using chimeric antigen receptors (CARs). This strategy is effective without the use of high-dose exogenous cytokines that are typically associated with toxicities. Moreover, we report that the persistence of the least differentiated memory T cell, the T-memory stem cell, was promoted by signaling induced by a membrane-bound chimeric IL-15 cytokine-fusion molecule. These findings may contribute to improving the safety and therapeutic efficacy of CAR-based immunotherapies of patients with advanced cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 2×
“With an observed high coexpression of CD45RA and CD45RO, we defined T-cell memory subsets by CD45RO and CCR7 expression (34, 35).”
BackgroundChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Self-citationKalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063 · cited 1×
“Conversely, when TAA is limited, such as with MRD, then activation solely through the CAR may be insufficient to maintain persistence (41).”
BackgroundA human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974 · cited 7×
“This preserved potential may have clinical appeal, because the least differentiated T-cell subset mediated the greatest therapeutic potential (7, 8).”
BackgroundMethodInfluentialLong, A. H., Haso, W. M., Shern, J. F., Wanhainen, K. M., Murgai, M., Ingaramo, M., Smith, J. P., Walker, A. J., Kohler, M. E., Venkateshwara, V. R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3838 · Cited by 1,815
Porter, D. L., Hwang, W.-T., Frey, N. V., Lacey, S. F., Shaw, P. A., Loren, A. W., Bagg, A., Marcucci, K. T., Shen, A., Gonzalez, V., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5415 · Cited by 1,729
Eshhar, Z., Waks, T., Gross, G., & Schindler, D. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.720 · Cited by 1,658
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Savoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., Kamble, R. T., Bollard, C. M., Gee, A. P., Mei, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46110 · Cited by 1,023 · cited 13×
“We assessed survival of mbIL15-CAR T cells in a model of minimal residual disease (MRD or low TAA burden), where adoptively transferred T cells may not immediately encounter and be stimulated by TAA, such as CD19.”
BackgroundInfluentialGSK3: a multifaceted kinase in Wnt signaling
Wu, D., & Pan, W. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.10.002 · Cited by 857
Berger, C., Jensen, M. C., Lansdorp, P. M., Gough, M., Elliott, C., & Riddell, S. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32103 · Cited by 824
Pipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J., & Rao, A. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.012 · Cited by 795
RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics
Lohse, M., Bolger, A. M., Nagel, A., Fernie, A. R., Lunn, J. E., Stitt, M., & Usadel, B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks540 · Cited by 786
Xu, Y., Zhang, M., Ramos, C. A., Durett, A., Liu, E., Dakhova, O., Liu, H., Creighton, C. J., Gee, A. P., Heslop, H. E., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552174 · Cited by 744
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
Zeng, R., Spolski, R., Finkelstein, S. E., Oh, S., Kovanen, P. E., Hinrichs, C. S., Pise-Masison, C. A., Radonovich, M. F., Brady, J. N., Restifo, N. P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041057 · Cited by 727
Conlon, K. C., Lugli, E., Welles, H. C., Rosenberg, S. A., Fojo, A. T., Morris, J. C., Fleisher, T. A., Dubois, S. P., Perera, L. P., Stewart, D. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.3329 · Cited by 711
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Denman, C. J., Senyukov, V. V., Somanchi, S. S., Phatarpekar, P. V., Kopp, L. M., Johnson, J. L., Singh, H., Hurton, L., Maiti, S. N., Huls, M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030264 · Cited by 683
Self-citationLifespan of human lymphocyte subsets defined by CD45 isoforms
Michie, C. A., McLean, A., Alcock, C., & Beverley, P. C. L. (1992) · Nature · doi:10.1038/360264a0 · Cited by 636
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Cieri, N., Camisa, B., Cocchiarella, F., Forcato, M., Oliveira, G., Provasi, E., Bondanza, A., Bordignon, C., Peccatori, J., Ciceri, F., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431718 · Cited by 625
Geginat, J., Lanzavecchia, A., & Sallusto, F. (2003) · Blood · doi:10.1182/blood-2002-11-3577 · Cited by 601
Paths to stemness: building the ultimate antitumour T cell
Gattinoni, L., Klebanoff, C. A., & Restifo, N. P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3322 · Cited by 599
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells
Klebanoff, C. A., Finkelstein, S. E., Surman, D. R., Lichtman, M. K., Gattinoni, L., Theoret, M. R., Grewal, N., Spiess, P. J., Antony, P. A., Palmer, D. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307298101 · Cited by 577
Hoyos, V, Savoldo, B., Quintarelli, C., Mahendravada, A., Zhang, M., Vera, J., Heslop, H. E., Rooney, C. M., Brenner, M. K., & Dotti, G. (2010) · Leukemia · doi:10.1038/leu.2010.75 · Cited by 567
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Kebriaei, P., Singh, H., Huls, M. H., Figliola, M. J., Bassett, R., Olivares, S., Jena, B., Dawson, M. J., Kumaresan, P. R., Su, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86721 · Cited by 500
Self-citationKowolik, C. M., Topp, M. S., Gonzalez, S., Pfeiffer, T., Olivares, S., Gonzalez, N., Smith, D. D., Forman, S. J., Jensen, M. C., & Cooper, L. J. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0160 · Cited by 487
Self-citationMatsuoka, K.-I., Koreth, J., Kim, H. T., Bascug, G., McDonough, S., Kawano, Y., Murase, K., Cutler, C., Ho, V. T., Alyea, E. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005265 · Cited by 468
Robbins, P. F., Dudley, M. E., Wunderlich, J., El-Gamil, M., Li, Y. F., Zhou, J., Huang, J., Powell, D. J., & Rosenberg, S. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7125 · Cited by 463
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H., Yamada, N., Feigenbaum, L., Waldmann, T. A., & Tagaya, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200363097 · Cited by 433
Sabatino, M., Hu, J., Sommariva, M., Gautam, S., Fellowes, V., Hocker, J. D., Dougherty, S., Qin, H., Klebanoff, C. A., Fry, T. J., et al. (2016) · Blood · doi:10.1182/blood-2015-11-683847 · Cited by 383
Fehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J., & Caligiuri, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.219 · Cited by 373
Combined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo
Stoklasek, T. A., Schluns, K. S., & Lefrançois, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6072 · Cited by 366
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
Dadi, S., Chhangawala, S., Whitlock, B. M., Franklin, R. A., Luo, C. T., Oh, S. A., Toure, A., Pritykin, Y., Huse, M., Leslie, C. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.002 · Cited by 359
Twelve immunotherapy drugs that could cure cancers
‘Mac’ Cheever, M. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00604.x · Cited by 341
Mortier, E., Quéméner, A., Vusio, P., Lorenzen, I., Boublik, Y., Grötzinger, J., Plet, A., & Jacques, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508624200 · Cited by 308
Hinrichs, C. S., Borman, Z. A., Gattinoni, L., Yu, Z., Burns, W. R., Huang, J., Klebanoff, C. A., Johnson, L. A., Kerkar, S. P., Yang, S., et al. (2011) · Blood · doi:10.1182/blood-2010-05-286286 · Cited by 307
Superior T memory stem cell persistence supports long-lived T cell memory
Lugli, E., Dominguez, M. H., Gattinoni, L., Chattopadhyay, P. K., Bolton, D. L., Song, K., Klatt, N. R., Brenchley, J. M., Vaccari, M., Gostick, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66327 · Cited by 302
Red-shifted Renilla reniformis luciferase variants for imaging in living subjects
Loening, A. M., Wu, A. M., & Gambhir, S. S. (2007) · Nature Methods · doi:10.1038/nmeth1070 · Cited by 287
Cooper, L. J. N., Topp, M. S., Serrano, L. M., Gonzalez, S., Chang, W.-C., Naranjo, A., Wright, C., Popplewell, L., Raubitschek, A., Forman, S. J., et al. (2003) · Blood · doi:10.1182/blood-2002-07-1989 · Cited by 248
Self-citationMemory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
Klebanoff, C. A., Scott, C. D., Leonardi, A. J., Yamamoto, T. N., Cruz, A. C., Ouyang, C., Ramaswamy, M., Roychoudhuri, R., Ji, Y., Eil, R. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81217 · Cited by 243
Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors
Teague, R. M., Sather, B. D., Sacks, J. A., Huang, M. Z., Dossett, M. L., Morimoto, J., Tan, X., Sutton, S. E., Cooke, M. P., Öhlén, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1359 · Cited by 233
Markley, J. C., & Sadelain, M. (2010) · Blood · doi:10.1182/blood-2009-09-241398 · Cited by 228
Rhode, P. R., Egan, J. O., Xu, W., Hong, H., Webb, G. M., Chen, X., Liu, B., Zhu, X., Wen, J., You, L., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0093-t · Cited by 225
Mlecnik, B., Bindea, G., Angell, H. K., Sasso, M. S., Obenauf, A. C., Fredriksen, T., Lafontaine, L., Bilocq, A. M., Kirilovsky, A., Tosolini, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007240 · Cited by 223
Burchill, M. A., Goetz, C. A., Prlic, M., O’Neil, J. J., Harmon, I. R., Bensinger, S. J., Turka, L. A., Brennan, P., Jameson, S. C., & Farrar, M. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5853 · Cited by 211
Rabinovich, B. A., Ye, Y., Etto, T., Chen, J. Q., Levitsky, H. I., Overwijk, W. W., Cooper, L. J. N., Gelovani, J., & Hwu, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804105105 · Cited by 208
Self-citationJonnalagadda, M., Mardiros, A., Urak, R., Wang, X., Hoffman, L. J., Bernanke, A., Chang, W.-C., Bretzlaff, W., Starr, R., Priceman, S., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.208 · Cited by 204
Singh, H., Figliola, M. J., Dawson, M. J., Huls, H., Olivares, S., Switzer, K., Mi, T., Maiti, S., Kebriaei, P., Lee, D. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3843 · Cited by 199
Self-citationImamura, M., Shook, D., Kamiya, T., Shimasaki, N., Chai, S. M. H., Coustan-Smith, E., Imai, C., & Campana, D. (2014) · Blood · doi:10.1182/blood-2014-02-556837 · Cited by 188
Deniger, D. C., Switzer, K., Mi, T., Maiti, S., Hurton, L., Singh, H., Huls, H., Olivares, S., Lee, D. A., Champlin, R. E., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.267 · Cited by 184
Self-citationSingh, H., Figliola, M. J., Dawson, M. J., Olivares, S., Zhang, L., Yang, G., Maiti, S., Manuri, P., Senyukov, V., Jena, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064138 · Cited by 170
Self-citationMishra, A., Liu, S., Sams, G. H., Curphey, D. P., Santhanam, R., Rush, L. J., Schaefer, D., Falkenberg, L. G., Sullivan, L., Jaroncyk, L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.009 · Cited by 169
Signal Integration by Akt Regulates CD8 T Cell Effector and Memory Differentiation
Kim, E. H., Sullivan, J. A., Plisch, E. H., Tejera, M. M., Jatzek, A., Choi, K. Y., & Suresh, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103568 · Cited by 156
Jena, B., Maiti, S., Huls, H., Singh, H., Lee, D. A., Champlin, R. E., & Cooper, L. J. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057838 · Cited by 134
Self-citationPletnev, S. V., Shcherbo, D., Chudakov, D. M., Pletneva, N. V., Merzlyak, E. M., Wlodawer, A., Dauter, Z., & Pletnev, V. Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800599200 · Cited by 125
Ji, Y., Wrzesinski, C., Yu, Z., Hu, J., Gautam, S., Hawk, N. V., Telford, W. G., Palmer, D. C., Franco, Z., Sukumar, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422916112 · Cited by 124
Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation
Stonier, S. W., Ma, L. J., Castillo, E. F., & Schluns, K. S. (2008) · Blood · doi:10.1182/blood-2008-05-156307 · Cited by 121
van der Waart, A. B., van de Weem, N. M. P., Maas, F., Kramer, C. S. M., Kester, M. G. D., Falkenburg, J. H. F., Schaap, N., Jansen, J. H., van der Voort, R., Gattinoni, L., et al. (2014) · Blood · doi:10.1182/blood-2014-05-578583 · Cited by 116
Homeostatic maintenance of T cells and natural killer cells
Boyman, O., Krieg, C., Homann, D., & Sprent, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0968-7 · Cited by 111
Hsu, C., Jones, S. A., Cohen, C. J., Zheng, Z., Kerstann, K., Zhou, J., Robbins, P. F., Peng, P. D., Shen, X., Gomes, T. J., et al. (2007) · Blood · doi:10.1182/blood-2006-06-029173 · Cited by 110
Mishra, A., Perle, K. L., Kwiatkowski, S., Sullivan, L. A., Sams, G. H., Johns, J., Curphey, D. P., Wen, J., McConnell, K. K., Qi, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1297 · Cited by 107
IL-15 Superagonist–Mediated Immunotoxicity: Role of NK Cells and IFN-γ
Guo, Y., Luan, L., Rabacal, W., Bohannon, J. K., Fensterheim, B. A., Hernandez, A., & Sherwood, E. R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500300 · Cited by 103
Sleeping Beauty System to Redirect T-cell Specificity for Human Applications
Maiti, S. N., Huls, H., Singh, H., Dawson, M., Figliola, M., Olivares, S., Rao, P., Zhao, Y. J., Multani, A., Yang, G., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182811ce9 · Cited by 82
Self-citationGrange, M., Verdeil, G., Arnoux, F., Griffon, A., Spicuglia, S., Maurizio, J., Buferne, M., Schmitt‐Verhulst, A., & Auphan‐Anezin, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300319 · Cited by 71
Castro, I., Yu, A., Dee, M. J., & Malek, T. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003961 · Cited by 64
Alwan, L. M., Grossmann, K. F., Sageser, D. S., Atta, J. V., Agarwal, N., & Gilreath, J. A. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0276-7 · Cited by 60
Grange, M., Buferne, M., Verdeil, G., Leserman, L., Schmitt‐Verhulst, A., & Auphan‐Anezin, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2187 · Cited by 49
Park, J. H., Rivière, I., Wang, X., Bernal, Y. J., Purdon, T. J., Halton, E. F., Wang, Y., Curran, K. J., Sauter, C. S., Sadelain, M., et al. (2015) · Blood · doi:10.1182/blood.v126.23.682.682 · Cited by 48
DAVIES, J. K., Singh, H., Huls, H. M., Yuk, D., Lee, D. A., Kebriaei, P., Champlin, R. E., Nadler, L. M., Guinan, E. C., & Cooper, L. J. N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3845 · Cited by 46
Self-citationHasan, A. N., Selvakumar, A., Shabrova, E. V., Xr, L., Afridi, F., Heller, G., Rivière, I., Sadelain, M., Dupont, B., & O'Reilly, R. J. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12816 · Cited by 46
Rowley, J. W., Monie, A., Hung, C., & Wu, T. ‐. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8237 · Cited by 36
Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes
Hunter, M. R., Prosser, M. E., Mahadev, V., Wang, X., Aguilar, B., Brown, C. E., Forman, S. J., & Jensen, M. C. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.03.021 · Cited by 18
Cited by
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Rafiq, S., Hackett, C. S., & Brentjens, R. J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0297-y · Cited by 1,472
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
Interleukins in cancer: from biology to therapy
Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00363-z · Cited by 781
CAR immune cells: design principles, resistance and the next generation
Labanieh, L., & Mackall, C. L. (2023) · Nature · doi:10.1038/s41586-023-05707-3 · Cited by 658
Metadata
- Authors
- Hurton, L. V., Singh, H., Najjar, A. M., Switzer, K. C., Mi, T., Maiti, S., Olivares, S., Rabinovich, B., Huls, H., Forget, M.-A., Datar, V., Kebriaei, P., Lee, D. A., Champlin, R. E., & Cooper, L. J. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2016-11-14
- Volume
- 113
- Issue
- 48
- Pages
- E7788-E7797
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2556133499
- Cited by
- 461
- References
- 76
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.